Home Tools
Log in

Search Result

Search Results for " cannabinoid receptor "



Cat No. Product Name Synonyms Targets
T2635 Org 27569 Cannabinoid Receptor
Org 27569, an allosteric modulator of cannabinoid CB1 receptor, can induce a CB1 receptor state that is characterized by decreased inverse agonist affinity and enhanced agonist affinity.
TN2268 Tetrahydromagnolol Cannabinoid Receptor , GPR , GABA Receptor
Tetrahydromagnolol can activate cannabinoid (CB) receptors.
T14011 2-Arachidonoylglycerol Cannabinoid Receptor , Endogenous Metabolite
In the central nervous system, 2-Arachidonoylglycerol is a second endogenous cannabinoid ligand
T7375 A-836339 Cannabinoid Receptor
A-836339 acts as a potent cannabinoid receptor full agonist which has a higher affinity for the peripheral CB2 receptor (Ki = 0.64 nM) over the central CB1 receptor (Ki = 270 nM). It displays analgesic, anti-inflammatory...
T7316 LY2828360 Cannabinoid Receptor
LY2828360 is a cannabinoid (CB) receptor 2 agonist (Ki = 40.3 nM). It selectively activates CB2 over CB1 in a GTPγS binding assay (EC50s = 20.1 and >100,000 nM, respectively).
T1915 AM251 Cannabinoid Receptor , GPR
AM251 is a effective CB1 receptor antagonist (IC50/Ki: 8 /7.49 nM) that displays 306-fold selectivity over CB2 receptors; also effective GPR55 agonist (EC50: 39 nM).
T2S0271 Voacamine Voacanginine Cannabinoid Receptor , P-gp
Voacamine (Voacanginine) is an indole alkaloid. Voacamine exhibits potent cannabinoid CB1 receptor antagonistic activity. Voacamine also inhibits P-glycoprotein (P-gp) action in multidrug-resistant tumor cells.Voacangini...
T3699 Bay 59-3074 Cannabinoid Receptor
Bay 59-3074 is a CB1/CB2 receptor partial agonist (Ki: 48.3/45.5 nM). In rat models of chronic neuropathic and inflammatory pain, it displays anti-hyperalgesic and antiallodynic properties.
T28468 PSNCBAM-1 PSNCBAM 1 Cannabinoid Receptor
PSNCBAM-1 (PSNCBAM 1) is a CB1 receptor negative allosteric modulator (EC50 = 0.1 μM) with hypophagic effects in vivo. PSNCBAM-1 can be used for obesity studies.
T4453 JD-5037 JD 5037 Cannabinoid Receptor
JD-5037 is a novel, peripherally restricted CB1R antagonist with an IC50 of 1.5 nM.
TN1465 Cannabigerol NOS , 5-HT Receptor , ROS
Cannabigerol is a high affinity α±2-adrenergic receptor agonist, moderate affinity 5-HT1A receptor antagonist, and low affinity CB1 receptor antagonist ; also binds to the CB2 receptor; it can relieve interocular pressur...
T10696 CB2 modulator 1 Cannabinoid Receptor
CB2 modulator 1 is a potent CB2 modulator. It can be used for the research for immune disorders, osteoporosis, inflammation, renal ischemia.
T8511 TM38837 Cannabinoid Receptor
TM38837 is an antagonist of cannabinoid receptor type 1 (CB1), with potential for the treatment of obesity and type 2 diabetes.
T9466 RTICBM-189 Others
RTICBM-189 is a potent, brain-penetrant allosteric modulator of the cannabinoid type-1 (CB1) receptor with a pIC50 of 7.54 in Ca2+ mobilization assay. RTICBM-189 has pIC50s of 5.29 and 6.25 for hCB1 and mCB1, respectivel...
T3530 Otenabant CP-945598 Cannabinoid Receptor
Otenabant (CP-945598) has been investigated for the treatment of Obesity.
T1519L Rimonabant SR141716 Cannabinoid Receptor , Antibacterial , Acyltransferase
Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its main avenue of effect is a reduction in appetite. Rimonabant...
T8425 Linoleoyl Ethanolamide TRP/TRPV Channel
Linoleoyl Ethanolamide is an endocannabinoid agent. It acts by binding to TRPV1 increasing ERK phosphorylation and AP-1 dependent transcription in CB-receptor in an independent manner.
T13803 N-Oleoyl glycine Cannabinoid Receptor , Akt , Endogenous Metabolite , PPAR
N-Oleoyl Glycine, a Lipoamino Acid, Stimulates Adipogenesis Associated With Activation of CB1 Receptor and Akt Signaling Pathway in 3T3-L1 Adipocyte
T4654 (±)-Ibipinabant (±)-BMS6462,SLV319,(±)-SLV319 Cannabinoid Receptor
(±)-Ibipinabant ((±)-SLV319) has been used in trials studying the treatment of Obesity and Obesity and Type 2 Diabetes.
T14881 CB1 antagonist 2 AM4113 Cannabinoid Receptor
CB1 antagonist 2 (AM4113) is caimabinoid 1 (CB1) antagonist which inhibits CB1 in vivo with an IC50 of 25.5 nM.
1 2 3 4 5 6 7 8 9